MULTIPLE SYSTEM ATROPHY
Clinical trials for MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could stem cells slow a rare fatal brain disease?
Disease control OngoingThis study tests if a person's own stem cells, injected into spinal fluid, can slow multiple system atrophy (MSA), a rare and fatal brain disease. About 71 adults with early-stage MSA will receive either stem cells or a placebo. The goal is to see if this treatment can slow disea…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Gene therapy takes on rare brain disease in first human safety trial
Disease control OngoingThis early-stage study tests whether a gene therapy called AAV2-GDNF is safe for people with Multiple System Atrophy (MSA), a rare and serious brain disorder. Nine adults aged 35-75 with MSA will receive either the gene therapy or a placebo through a brain injection. The main goa…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Hope for MSA: experimental drug aims to slow rare brain disease
Disease control OngoingThis study tests an experimental drug called Lu AF82422 in 64 people with multiple system atrophy (MSA), a rare and serious brain disease. The goal is to see if the drug can slow down the worsening of symptoms like movement problems and daily living difficulties. Participants rec…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug trial aims to tame Parkinson's and MSA
Disease control OngoingThis study tests a new medicine called exidavnemab in people with mild to moderate Parkinson's disease or multiple system atrophy (MSA). The main goal is to check if the drug is safe and tolerable. Participants will receive either the drug or a placebo, and researchers will monit…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2 • Sponsor: BioArctic AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Hope for MSA: new drug aims to slow deadly brain disease
Disease control OngoingThis phase 3 trial tests a drug called amlenetug in 401 people with multiple system atrophy (MSA), a rare and serious brain disorder. The goal is to see if the drug can slow the disease's progression and help people live longer. Participants receive either the drug or a placebo, …
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE3 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Can online communities ease the burden of Parkinson's and dementia?
Symptom relief OngoingThis study looks at whether online palliative care training for doctors and telemedicine support can improve quality of life for people with Parkinson's disease, Lewy body dementia, and similar conditions, as well as their caregivers. About 632 patients and their care partners ar…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated May 17, 2026 05:08 UTC
-
Global study tracks MSA progression to unlock clues for future treatments
Knowledge-focused OngoingThis study follows 90 people with Multiple System Atrophy (MSA) in China and Europe for 12 months to understand how the disease progresses. Researchers will use regular check-ups, brain scans, and blood tests to measure changes. The goal is to gather information that could help d…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: H. Lundbeck A/S • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC
-
Tiny vein study could unlock blood pressure secrets in rare brain disease
Knowledge-focused OngoingThis study looks at how the nervous system controls blood flow in abdominal veins and how that might contribute to high blood pressure in people with Multiple System Atrophy (MSA). Researchers will test a drug that temporarily blocks nerve signals to see how it changes vein funct…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE1 • Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New study aims to sharpen diagnosis of nerve system disorders
Knowledge-focused OngoingThis study aims to improve how doctors test for chronic autonomic failure, a condition where the body's automatic functions like blood pressure control don't work properly. It includes people with Parkinson's disease, multiple system atrophy, or related issues. Participants under…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New study maps how Parkinson's and MSA worsen over time
Knowledge-focused OngoingThis study follows 150 people with early Parkinson's disease or Multiple System Atrophy (MSA) for up to 18 months. Researchers measure changes in movement, daily living, and quality of life to better understand how these conditions progress. The goal is to gather detailed informa…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: AskBio Inc • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC